Patient demographics and comparison between patients with and without non-cancer-related adverse events within 1 year
Characteristics . | All cases (n = 460) . | Non-cancer-related adverse events within 1 year . | P-value . | ||||
---|---|---|---|---|---|---|---|
No (n = 366) (84%)a . | Yes (n = 94) (16%)a . | ||||||
Age (years) | 71 (64–76) | 70 (63–46) | 74 (69–78) | 0.003 | |||
Sex | |||||||
Male | 248 (54) | 183 (50) | 65 (69) | 0.001 | |||
Female | 212 (46) | 183 (50) | 29 (31) | ||||
BMI (kg/m2) | 23 (20–25) | 23 (21–25) | 22 (20–25) | 0.27 | |||
Smoking history | |||||||
Never | 205 (44) | 172 (47) | 33 (35) | 0.048 | |||
Former | 242 (53) | 186 (51) | 56 (60) | ||||
Current | 13 (3) | 8 (2) | 5 (5) | ||||
Hypertension | |||||||
No | 241 (52) | 191 (52) | 50 (53) | 0.86 | |||
Yes | 219 (48) | 175 (48) | 44 (47) | ||||
Coronary artery disease | |||||||
No | 418 (91) | 338 (92) | 80 (85) | 0.030 | |||
Yes | 42 (9) | 28 (8) | 14 (15) | ||||
Diabetes mellitus | |||||||
No | 365 (79) | 291 (80) | 74 (79) | 0.87 | |||
Yes | 95 (21) | 75 (20) | 20 (21) | ||||
History of atrial fibrillation | |||||||
No | 433 (94) | 346 (95) | 87 (93) | 0.47 | |||
Yes | 27 (6) | 20 (5) | 7 (7) | ||||
Chemotherapy | |||||||
No | 448 (97) | 357 (98) | 91 (97) | 0.69 | |||
Yes | 12 (3) | 9 (2) | 3 (3) | ||||
BNP (pg/ml) | 23 (13–41) | 22 (12–38) | 31 (17–56) | 0.002 | |||
%FEV1 (%) | 99 (86–113) | 100 (88–113) | 90 (77–110) | 0.002 | |||
Surgical approach | |||||||
MIS | 382 (83) | 312 (85) | 70 (75) | 0.013 | |||
Thoracotomy | 78 (17) | 54 (15) | 24 (25) | ||||
Surgery | |||||||
Segmentectomy | 162 (35) | 135 (37) | 27 (29) | 0.14 | |||
Lobectomy | 298 (65) | 231 (63) | 67 (71) | ||||
Number of resected subsegments | 6 (4–10) | 6 (4–10) | 10 (6–10) | 0.003 | |||
POAF | |||||||
No | 421 (92) | 342 (93) | 79 (84) | 0.004 | |||
Yes | 39 (8) | 24 (7) | 15 (16) |
Characteristics . | All cases (n = 460) . | Non-cancer-related adverse events within 1 year . | P-value . | ||||
---|---|---|---|---|---|---|---|
No (n = 366) (84%)a . | Yes (n = 94) (16%)a . | ||||||
Age (years) | 71 (64–76) | 70 (63–46) | 74 (69–78) | 0.003 | |||
Sex | |||||||
Male | 248 (54) | 183 (50) | 65 (69) | 0.001 | |||
Female | 212 (46) | 183 (50) | 29 (31) | ||||
BMI (kg/m2) | 23 (20–25) | 23 (21–25) | 22 (20–25) | 0.27 | |||
Smoking history | |||||||
Never | 205 (44) | 172 (47) | 33 (35) | 0.048 | |||
Former | 242 (53) | 186 (51) | 56 (60) | ||||
Current | 13 (3) | 8 (2) | 5 (5) | ||||
Hypertension | |||||||
No | 241 (52) | 191 (52) | 50 (53) | 0.86 | |||
Yes | 219 (48) | 175 (48) | 44 (47) | ||||
Coronary artery disease | |||||||
No | 418 (91) | 338 (92) | 80 (85) | 0.030 | |||
Yes | 42 (9) | 28 (8) | 14 (15) | ||||
Diabetes mellitus | |||||||
No | 365 (79) | 291 (80) | 74 (79) | 0.87 | |||
Yes | 95 (21) | 75 (20) | 20 (21) | ||||
History of atrial fibrillation | |||||||
No | 433 (94) | 346 (95) | 87 (93) | 0.47 | |||
Yes | 27 (6) | 20 (5) | 7 (7) | ||||
Chemotherapy | |||||||
No | 448 (97) | 357 (98) | 91 (97) | 0.69 | |||
Yes | 12 (3) | 9 (2) | 3 (3) | ||||
BNP (pg/ml) | 23 (13–41) | 22 (12–38) | 31 (17–56) | 0.002 | |||
%FEV1 (%) | 99 (86–113) | 100 (88–113) | 90 (77–110) | 0.002 | |||
Surgical approach | |||||||
MIS | 382 (83) | 312 (85) | 70 (75) | 0.013 | |||
Thoracotomy | 78 (17) | 54 (15) | 24 (25) | ||||
Surgery | |||||||
Segmentectomy | 162 (35) | 135 (37) | 27 (29) | 0.14 | |||
Lobectomy | 298 (65) | 231 (63) | 67 (71) | ||||
Number of resected subsegments | 6 (4–10) | 6 (4–10) | 10 (6–10) | 0.003 | |||
POAF | |||||||
No | 421 (92) | 342 (93) | 79 (84) | 0.004 | |||
Yes | 39 (8) | 24 (7) | 15 (16) |
Data are shown as number (%) or median (25–75 percentiles).
Percentages among all 460 patients.
BMI: body mass index; BNP: brain natriuretic peptide; %FEV1: percentage-predicted forced expiratory volume in 1 s; MIS: minimally invasive surgery; POAF: postoperative atrial fibrillation.
The bold font indicates statistical significance.
Patient demographics and comparison between patients with and without non-cancer-related adverse events within 1 year
Characteristics . | All cases (n = 460) . | Non-cancer-related adverse events within 1 year . | P-value . | ||||
---|---|---|---|---|---|---|---|
No (n = 366) (84%)a . | Yes (n = 94) (16%)a . | ||||||
Age (years) | 71 (64–76) | 70 (63–46) | 74 (69–78) | 0.003 | |||
Sex | |||||||
Male | 248 (54) | 183 (50) | 65 (69) | 0.001 | |||
Female | 212 (46) | 183 (50) | 29 (31) | ||||
BMI (kg/m2) | 23 (20–25) | 23 (21–25) | 22 (20–25) | 0.27 | |||
Smoking history | |||||||
Never | 205 (44) | 172 (47) | 33 (35) | 0.048 | |||
Former | 242 (53) | 186 (51) | 56 (60) | ||||
Current | 13 (3) | 8 (2) | 5 (5) | ||||
Hypertension | |||||||
No | 241 (52) | 191 (52) | 50 (53) | 0.86 | |||
Yes | 219 (48) | 175 (48) | 44 (47) | ||||
Coronary artery disease | |||||||
No | 418 (91) | 338 (92) | 80 (85) | 0.030 | |||
Yes | 42 (9) | 28 (8) | 14 (15) | ||||
Diabetes mellitus | |||||||
No | 365 (79) | 291 (80) | 74 (79) | 0.87 | |||
Yes | 95 (21) | 75 (20) | 20 (21) | ||||
History of atrial fibrillation | |||||||
No | 433 (94) | 346 (95) | 87 (93) | 0.47 | |||
Yes | 27 (6) | 20 (5) | 7 (7) | ||||
Chemotherapy | |||||||
No | 448 (97) | 357 (98) | 91 (97) | 0.69 | |||
Yes | 12 (3) | 9 (2) | 3 (3) | ||||
BNP (pg/ml) | 23 (13–41) | 22 (12–38) | 31 (17–56) | 0.002 | |||
%FEV1 (%) | 99 (86–113) | 100 (88–113) | 90 (77–110) | 0.002 | |||
Surgical approach | |||||||
MIS | 382 (83) | 312 (85) | 70 (75) | 0.013 | |||
Thoracotomy | 78 (17) | 54 (15) | 24 (25) | ||||
Surgery | |||||||
Segmentectomy | 162 (35) | 135 (37) | 27 (29) | 0.14 | |||
Lobectomy | 298 (65) | 231 (63) | 67 (71) | ||||
Number of resected subsegments | 6 (4–10) | 6 (4–10) | 10 (6–10) | 0.003 | |||
POAF | |||||||
No | 421 (92) | 342 (93) | 79 (84) | 0.004 | |||
Yes | 39 (8) | 24 (7) | 15 (16) |
Characteristics . | All cases (n = 460) . | Non-cancer-related adverse events within 1 year . | P-value . | ||||
---|---|---|---|---|---|---|---|
No (n = 366) (84%)a . | Yes (n = 94) (16%)a . | ||||||
Age (years) | 71 (64–76) | 70 (63–46) | 74 (69–78) | 0.003 | |||
Sex | |||||||
Male | 248 (54) | 183 (50) | 65 (69) | 0.001 | |||
Female | 212 (46) | 183 (50) | 29 (31) | ||||
BMI (kg/m2) | 23 (20–25) | 23 (21–25) | 22 (20–25) | 0.27 | |||
Smoking history | |||||||
Never | 205 (44) | 172 (47) | 33 (35) | 0.048 | |||
Former | 242 (53) | 186 (51) | 56 (60) | ||||
Current | 13 (3) | 8 (2) | 5 (5) | ||||
Hypertension | |||||||
No | 241 (52) | 191 (52) | 50 (53) | 0.86 | |||
Yes | 219 (48) | 175 (48) | 44 (47) | ||||
Coronary artery disease | |||||||
No | 418 (91) | 338 (92) | 80 (85) | 0.030 | |||
Yes | 42 (9) | 28 (8) | 14 (15) | ||||
Diabetes mellitus | |||||||
No | 365 (79) | 291 (80) | 74 (79) | 0.87 | |||
Yes | 95 (21) | 75 (20) | 20 (21) | ||||
History of atrial fibrillation | |||||||
No | 433 (94) | 346 (95) | 87 (93) | 0.47 | |||
Yes | 27 (6) | 20 (5) | 7 (7) | ||||
Chemotherapy | |||||||
No | 448 (97) | 357 (98) | 91 (97) | 0.69 | |||
Yes | 12 (3) | 9 (2) | 3 (3) | ||||
BNP (pg/ml) | 23 (13–41) | 22 (12–38) | 31 (17–56) | 0.002 | |||
%FEV1 (%) | 99 (86–113) | 100 (88–113) | 90 (77–110) | 0.002 | |||
Surgical approach | |||||||
MIS | 382 (83) | 312 (85) | 70 (75) | 0.013 | |||
Thoracotomy | 78 (17) | 54 (15) | 24 (25) | ||||
Surgery | |||||||
Segmentectomy | 162 (35) | 135 (37) | 27 (29) | 0.14 | |||
Lobectomy | 298 (65) | 231 (63) | 67 (71) | ||||
Number of resected subsegments | 6 (4–10) | 6 (4–10) | 10 (6–10) | 0.003 | |||
POAF | |||||||
No | 421 (92) | 342 (93) | 79 (84) | 0.004 | |||
Yes | 39 (8) | 24 (7) | 15 (16) |
Data are shown as number (%) or median (25–75 percentiles).
Percentages among all 460 patients.
BMI: body mass index; BNP: brain natriuretic peptide; %FEV1: percentage-predicted forced expiratory volume in 1 s; MIS: minimally invasive surgery; POAF: postoperative atrial fibrillation.
The bold font indicates statistical significance.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.